National Tuberculosis and Lung Diseases Research Institute, Department of Tuberculosis Epidemiology and Surveillance.
Przegl Epidemiol. 2020;74(2):239-257. doi: 10.32394/pe.74.19.
To evaluate the main features of tuberculosis (TB) epidemiology in 2018 in Poland and to compare with the situation in the EU/EEA countries.
Analysis of case- based data on TB patients from National TB Register, data on anti-TB drug susceptibility testing results in cases notified in 2018, data from National Institute of Public Health- National Institute of Hygiene on HIV-positive subjects for whom TB was an AIDS-defining disease, data from Central Statistical Office on deaths from tuberculosis based on death certificates, data from the report " European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2020- 2018 data. Stockholm: European Centre for Disease Prevention and Control, 2020".
In 2018, 5487 TB cases were reported in Poland. The incidence rate was 14.3 cases per 100000, with large variability between voivodeships from 7.3 to 23.4 per 100 000. The mean annual decrease of TB incidence in 2014- 2018 was 3.8%. In 2018, 4852 cases were newly diagnosed with no history of previous treatment i.e. 12.6 per 100 000. 635 cases i.e. 1.7 per 100 000 - 11.6% of all registered subjects were previously treated for tuberculosis. In 2018, the number of all pulmonary tuberculosis cases was 5224 i.e. 13.7 per 100000. Pulmonary cases represented 95.2% of all TB cases. In 2018, 243 extrapulmonary TB cases were found i.e. 0.6 per 100 000. In the whole country there were 52 pediatric cases of tuberculosis. TB in children represented 0.9% of all cases notified in Poland in 2018. The incidence rates of tuberculosis were growing along with the age group from 0.9 per 100 000 among children to 24.7 per 100 000 among subjects in the age group 45-64 years (the highest incidence rate). In 2018, the incidence rate in the age group ≥65 years was 21.3 per 100 000. The TB incidence among men i.e. 21.0 per 100 000 was 2.6 times higher than among women i.e. 8.0 per 100 000. The biggest difference in the TB incidence between the two sex groups occurred in persons aged 55 to 59 years - 44.9 vs. 9.8 and in age group 60- 64 years - 43.7 vs. 10.2. The TB incidence in rural population was lower than in urban, respectively 13.4 per 100 000 and 14.9 per 100 000. The number of all registered culture positive TB cases was 4075. Pulmonary tuberculosis was bacteriologically confirmed in 3935 subjects. Cases confirmed by culture represented 74.3% of all TB cases and 75.3% of all pulmonary TB cases. The number of smear-positive pulmonary TB cases reported in 2018 was 2324 i.e. 6.1 per 100 000 accounting for 44.3% of all pulmonary TB cases and 59.1% of pulmonary TB cases confirmed by culture. In all patients with tuberculosis in Poland in 2018 there were 48 cases with MDR-TB (among them 14 foreigners) and 83 patients with resistance to isoniazid only, representing respectively 1.3% and 2.2% of cases with known DST results (DSTs were available in 90.7% of all culture-confirmed TB cases). In 2018, there were 97 patients of foreign origin among all cases of tuberculosis in Poland. TB was AIDS-indicative disease in 14 subjects with HIV co-infection. There were 490 deaths due to tuberculosis reported in 2017 - 1.3 per 100 000; 468 people died from pulmonary and 22 from extrapulmonary tuberculosis. Mortality among males - 2.1 per 100 000 - was 3.6 X higher than among females - 0.5. 40.2% of all TB deaths were cases 65 years old and older - 3.1 per 100 000. In 2017, there was no death from tuberculosis in children and no deaths in adolescents. In 2017, tuberculosis represented 0.1% of total mortality in Poland and 25.4% of mortality from infectious and parasitic diseases.
In 2018, the incidence of tuberculosis in Poland was lower than in 2017. Despite a continuous decline it is still higher than the average in the EU/EEA countries. The highest incidence rates were observed in older age groups. The participation of pediatric cases is smaller than average in the EU/EEA countries. The incidence in males was more than 2 times higher than in females. The impact of migration on the characteristics of tuberculosis in Poland is not substantial. In Poland, MDR-TB is less common than the average in the EU/EEA countries.
评估 2018 年波兰结核病(TB)流行病学的主要特征,并与欧盟/欧洲经济区国家的情况进行比较。
分析国家结核病登记处的基于病例数据、2018 年报告的抗结核药物敏感性检测结果数据、国家公共卫生-国家卫生研究所报告的 HIV 阳性人群中结核病为艾滋病定义性疾病的数据、中央统计局的基于死亡证明的结核病死亡数据、欧洲疾病预防控制中心/世界卫生组织欧洲区域办事处的“欧洲 2020 年结核病监测和监测报告-2018 年数据”。
2018 年,波兰报告了 5487 例结核病病例。发病率为每 100000 人 14.3 例,各省份之间差异很大,从每 100000 人 7.3 例到 23.4 例不等。2014-2018 年结核病发病率平均每年下降 3.8%。2018 年,4852 例为初治无既往治疗史的新发病例,即每 100000 人 12.6 例。635 例,即每 100000 人 1.7%,是以前接受过结核病治疗的人。2018 年,所有肺结核病例数为 5224 例,即每 100000 人 13.7 例。肺病例占所有结核病病例的 95.2%。2018 年,发现 243 例肺外结核病例,即每 100000 人 0.6 例。在全国范围内,有 52 例儿童结核病病例。2018 年,儿童结核病占波兰报告病例的 0.9%。结核病发病率随着年龄组的增加而增加,从儿童组的 0.9/100000 到 45-64 岁组的 24.7/100000(发病率最高)。2018 年,65 岁以上年龄组的发病率为 21.3/100000。男性结核病发病率为 21.0/100000,是女性 8.0/100000 的 2.6 倍。两组性别之间结核病发病率的最大差异发生在 55-59 岁年龄组,即 44.9 比 9.8 和 60-64 岁年龄组,即 43.7 比 10.2。农村人口的结核病发病率低于城市,分别为每 100000 人 13.4 和每 100000 人 14.9。所有登记的培养阳性结核病病例数为 4075 例。3935 例经培养确诊为肺结核。培养确诊病例占所有结核病病例的 74.3%,占所有肺结核病例的 75.3%。2018 年报告的涂阳肺结核病例数为 2324 例,即每 100000 人 6.1 例,占所有肺结核病例的 44.3%,占培养阳性肺结核病例的 59.1%。2018 年,波兰所有结核病患者中有 48 例耐多药结核病(其中 14 例为外国人)和 83 例耐异烟肼结核病,分别占已知药敏试验结果病例的 1.3%和 2.2%(90.7%的培养确诊结核病病例可获得药敏试验结果)。2018 年,波兰所有结核病患者中有 97 例来自国外。14 例 HIV 合并感染者中,有 14 例结核病为艾滋病定义性疾病。2017 年报告了 490 例结核病死亡,即每 100000 人 1.3 例;468 人死于肺结核,22 人死于肺外结核。男性死亡率为 2.1/100000,是女性 0.5/100000 的 3.6 倍。所有结核病死亡中,65 岁及以上的占 40.2%,即每 100000 人 3.1 例。2017 年,儿童无结核病死亡,青少年无结核病死亡。2017 年,结核病占波兰总死亡率的 0.1%,占传染病和寄生虫病死亡率的 25.4%。
2018 年,波兰的结核病发病率低于 2017 年。尽管持续下降,但仍高于欧盟/欧洲经济区国家的平均水平。发病率最高的年龄组是老年人。儿科病例的比例低于欧盟/欧洲经济区国家的平均水平。男性发病率是女性的两倍多。移民对波兰结核病特征的影响不大。波兰耐多药结核病的发病率低于欧盟/欧洲经济区国家的平均水平。